Cayman Chemical
Cayman Chemical Company, founded in 1980, is a leading supplier for the life sciences and biomedical research industry, serving academic, pharmaceutical, and biotechnology markets worldwide. With the mission Helping make research possible, the company is renowned for delivering high-quality tools and contract services.
Cayman’s expertise lies in the synthesis, purification, and characterization of complex biochemicals linked to cellular signaling and disease pathways. Its portfolio covers biochemicals and small molecules, including inhibitors, activators, metabolites, and signaling molecules for cancer, inflammation, neuroscience, epigenetics, and metabolism research. A historic strength is lipid research, with high-purity eicosanoids, sphingolipids, and fatty acids. The company also develops lipid nanoparticles (LNPs), offering ready-made and custom lipids such as ionizable cationic lipids for nucleic acid delivery, including mRNA vaccines.
In addition, Cayman provides a broad selection of assay kits, from ELISAs to enzyme activity assays, many based on its patented AChE® technology for enhanced sensitivity. The company is also a recognized supplier of forensic and analytical standards, delivering ISO/IEC 17025 and ISO 17034-accredited Certified Reference Materials (CRMs) for toxicology and forensic labs, including standards for synthetic cannabinoids and cathinones.
